On 10 Aug 2000, Sean Eddy wrote:
> Actually I think that's a Good Thing. Supporting and documenting
> software properly is clearly a commercial activity. I think there's a
> reasonable niche market for software companies that repackage and
> support open source bioinformatics packages in robust, user-friendly
> ways.
Yes, I agree there is demand for these activities which clearly are
best dealt with in a commercial setting (i.e. financed by private money).
On the contrary, the research that lead to the raw, unsupported piece of
software/database etc. was most likely funded by public money, and as such
it should be shared freely.
Korbinian
